Discovery of Metastatic Breast Cancer Suppressor Genes Using Functional Genome Analysis

2012 ◽  
Author(s):  
Xiaoxing Wang
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Genome Analysis ◽  
Metastatic Breast ◽  
Suppressor Genes ◽  
Functional Genome

scholarly journals SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis

2016 ◽  
Vol 113 (3) ◽  
pp. 638-643 ◽  
Author(s):  
Sait Ozturk ◽  
Panagiotis Papageorgis ◽  
Chen Khuan Wong ◽  
Arthur W. Lambert ◽  
Hamid M. Abdolmaleky ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cell Lines ◽  
Cancer Progression ◽  
Metastatic Breast ◽  
Breast Cancer Progression ◽  
Metastasis Suppressor ◽  
Suppressor Genes ◽  
Metastasis Suppressor Genes ◽  
Model Cell

Metastatic dissemination of breast cancer cells represents a significant clinical obstacle to curative therapy. The loss of function of metastasis suppressor genes is a major rate-limiting step in breast cancer progression that prevents the formation of new colonies at distal sites. However, the discovery of new metastasis suppressor genes in breast cancer using genomic efforts has been slow, potentially due to their primary regulation by epigenetic mechanisms. Here, we report the use of model cell lines with the same genetic lineage for the identification of a novel metastasis suppressor gene, serum deprivation response (SDPR), localized to 2q32-33, a region reported to be associated with significant loss of heterozygosity in breast cancer. In silico metaanalysis of publicly available gene expression datasets suggests that the loss of expression of SDPR correlates with significantly reduced distant-metastasis–free and relapse-free survival of breast cancer patients who underwent therapy. Furthermore, we found that stable SDPR overexpression in highly metastatic breast cancer model cell lines inhibited prosurvival pathways, shifted the balance of Bcl-2 family proteins in favor of apoptosis, and decreased migration and intravasation/extravasation potential, with a corresponding drastic suppression of metastatic nodule formation in the lungs of NOD/SCID mice. Moreover, SDPR expression is silenced by promoter DNA methylation, and as such it exemplifies epigenetic regulation of metastatic breast cancer progression. These observations highlight SDPR as a potential prognostic biomarker and a target for future therapeutic applications.

Sign in / Sign up

Export Citation Format

Share Document